All-Cause, CVD, DM Mortality Down From 2000 to 2011

This article originally appeared here.
Share this content:
All-Cause, CVD, DM Mortality Down From 2000 to 2011
All-Cause, CVD, DM Mortality Down From 2000 to 2011

TUESDAY, May 3, 2016 (HealthDay News) -- All-cause and certain cause-specific mortality rates have decreased recently among those with type 1 and 2 diabetes, although younger patients have seen less improvement, according to a study published online April 26 in Diabetes Care.

Jessica L. Harding, from the Baker IDI Heart and Diabetes Institute in Melbourne, Australia, and colleagues used data for 1,189,079 Australians with diabetes registered on the National Diabetes Service Scheme between 2000 and 2011. These data were linked to the National Death Index. The authors age standardized mortality rates in the total population to the 2001 Australian population.

The researchers found that between 2000 and 2011, all-cause, cardiovascular disease (CVD), and diabetes age-standardized mortality rates (ASMRs) decreased each year by 0.61, 0.35, and 0.14 per 1,000 person-years, respectively, for type 1 diabetes (Ptrend < 0.05); there was no change in cancer mortality. All age groups had significant decreases in all-cause, CVD, and diabetes mortality rates, except for diabetes mortality in those aged 0 to 40 years. For type 2 diabetes, the corresponding decreases in all-cause, CVD, and diabetes ASMRs were 0.18, 0.15, and 0.03 per 1,000 person-years, respectively (Ptrend < 0.001), with no change in cancer mortality. These decreases were seen in all age groups apart from those aged 0 to 40 years, where significant increases in all-cause and cancer mortality were observed.

"Younger populations are not benefiting from the same improvements as older populations," the authors write. "The absence of a decline in cancer mortality warrants urgent attention."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »